4

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: October 23, 2015
Period of Report: October 23, 2015
Accession Number: 0000908662-15-000319

View Document ↗ View on SEC.gov ↗